| Stage | LIVN | % of rev | MDT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $393M | 100.00% | $9.8B | 100.00% | MDT ×24.82 |
| Gross profit | $265M | 67.42% | $6.3B | 64.99% | LIVN +2.4pp |
| Operating income | $28M | 7.23% | $1.8B | 18.08% | MDT +10.9pp |
| Pre-tax income | $47M | 11.90% | $1.8B | 18.13% | MDT +6.2pp |
| Net income | $34M | 8.72% | $1.5B | 15.16% | MDT +6.4pp |
| Stage | LIVN | MDT | Gap · A − B |
|---|---|---|---|
| Revenue | $393M100.00% | $9.8B100.00% | MDT ×24.82 |
| Gross profit | 67.42%$265M | 64.99%$6.3B | LIVN +2.4pp |
| Operating income | 7.23%$28M | 18.08%$1.8B | MDT +10.9pp |
| Pre-tax income | 11.90%$47M | 18.13%$1.8B | MDT +6.2pp |
| Net income |
| 8.72%$34M |
| 15.16%$1.5B |
| MDT +6.4pp |
No shared counterparties.